Middle East Life Science Tools Market To Reach $4.28 Billion By 2033

Middle East Life Science Tools Market Growth & Trends

The Middle East life science tools market size is projected to reach USD 4.28 billion by 2033, growing at a CAGR of 6.7% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is experiencing robust growth, driven by significant investments in healthcare infrastructure and R&D capacity.

Governments across the Gulf, particularly in Saudi Arabia and the UAE, are prioritizing the development of advanced laboratories, biobanks, and training facilities to support national health strategies and strengthen local research ecosystems. This sustained investment is boosting demand for sophisticated tools, including sequencing platforms, mass spectrometry systems, and laboratory automation solutions, as academic institutions, research centers, and pharmaceutical companies scale their capabilities.

Another key growth driver is the rapid adoption of precision medicine and multi-omics approaches. Initiatives such as the Emirati Genome Programme, which has already sequenced over 800,000 genomes, are creating rich datasets that enable population-specific insights, supporting early disease detection and personalized therapies. As oncology, rare disease, and genetic disorder research accelerates, demand is rising for high-throughput sequencing, bioinformatics, and single-cell analysis platforms that can deliver actionable clinical insights.

Policy support and collaborative partnerships are also shaping market momentum. Abu Dhabi recently launched the “Declaration on Longevity and Precision Medicine,” backed by global players such as Illumina and M42, to promote AI-enabled diagnostics and innovative treatment solutions. Similarly, the formation of AD-Omics, a joint venture between IHLAD and Singleron Biotechnologies, aims to bring advanced single-cell and genomic diagnostic technologies to the region. In parallel, M42’s collaboration with AstraZeneca is expanding companion diagnostics for hereditary breast cancer, showcasing how strategic partnerships are translating global innovation into regional clinical practice and creating strong demand for cutting-edge life science tools.

 Request a free sample copy or view report summary: Middle East Life Science Tools Market Report

Middle East Life Science Tools Market Report Highlights

• Based on technology, cell biology technology segment captured the largest revenue share of 33.73% in 2024. The market for cell biology technology is gaining momentum as regional investments in research infrastructure and biopharma manufacturing expand rapidly.

• Based on product & service, the next generation sequencing segment is expected to grow fastest during the forecast period. Government funding, partnerships with global genomics leaders, and the establishment of regional sequencing hubs are accelerating infrastructure development, making NGS a central pillar of research, clinical diagnostics, and population health strategies across the region.

• Based on end-use, the healthcare segment dominated the market with the largest revenue share of 32.50% in 2024. With the growing prevalence of non-communicable diseases such as cancer, diabetes, and cardiovascular conditions, the reliance on sophisticated life science tools to enhance clinical decision-making and improve population health management is increasing rapidly.

Middle East Life Science Tools Market Segmentation

Grand View Research has segmented the Middle East life science tools market based on technology, product & service, end-use, and country:

Middle East Life Science Tools Technology Outlook (Revenue, USD Million, 2021 - 2033)

• Genomic Technology

• Proteomics Technology

• Cell Biology Technology

• Other Analytical & Sample Preparation Technology

• Lab Supplies & Technologies

Middle East Life Science Tools Product & Service Outlook (Revenue, USD Million, 2021 - 2033)

• Cell Culture Systems & 3D Cell Culture

  • Instruments

  • Consumables

  • Cell & Tissue Culture Services

• Liquid Chromatography

  • Instruments

  • Consumables

  • Services

• Mass Spectrometry

  • Instruments

  • Consumables

  • Services

• Flow Cytometry

  • Instruments

  • Consumables

  • Services

• Cloning & Genome Engineering

  • Kits, Reagents, and Consumables

  • Services

• Microscopy & Electron Microscopy

  • Instruments

  • Consumables

  • Services

• Next Generation Sequencing

  • Instruments

  • Consumables

  • Services

• PCR & qPCR

  • Instruments

  • Consumables

  • Services

• Nucleic Acid Preparation

  • Instruments

  • Consumables

  • Services

• Nucleic Acid Microarray

  • Instruments

  • Consumables

  • Services

• Sanger Sequencing

  • Instruments

  • Consumables

  • Services

• Transfection Devices & Gene Delivery Technologies

  • Equipment

  • Reagents

• NMR

  • Instruments

  • Consumables

  • Services

• Other Separation Technologies

  • Instruments

  • Consumables

  • Services

• Other Products & Services

  • Antibodies

  • General Supplies

  • Others

    • Instruments

    • Consumables

    • Services

Middle East Life Science Tools End-use Outlook (Revenue, USD Million, 2021 - 2033)

• Government & Academic

• Biopharmaceutical Company

• Healthcare

• Industrial Applications

• Others

Middle East Life Science Tools Country Outlook (Revenue, USD Million, 2021 - 2033)

• Saudi Arabia

• UAE

• Kuwait

• Qatar

• Oman

List of Key Players in the Middle East Life Science Tools Market

• Agilent Technologies, Inc.

• Becton, Dickinson and Company

• F. Hoffmann-La Roche Ltd.

• Bio-Rad Laboratories, Inc.

• Danaher Corporation

• Illumina, Inc.

• Thermo Fisher Scientific, Inc.

• QIAGEN N.V.

• Merck KGaA

• Shimadzu Corporation